2. Phuong, T.; Khac-Minh, T.; Van Hal, N. T.; Phuong, H. T. Synthesis
and antifungal activities of phenylenedithioureas. Bioorg. Med.
Chem. Lett. 2004, 14, 653–656.
3. Huebhr, O. F.; Marsh, J. L.; Mizzoni, R. H.; Mull, R. P.; Schroeder, D.
C.; Troxell, H. A.; Scholz, C. R. A new class of antitubercular
compounds. J. Am. Chem. Soc. 1953, 75, 2274–2275.
4. Ramadas, K.; Suresh, G.; Janarthanan, N.; Masilamani, S. Antifungal
activity of 1,3-disubstituted symmetrical and unsymmetrical
thioureas. Pestic. Sci. 1998, 52, 145–151.
addition of 5 mM ferrozine (0.2 mL) and the mixture
was shaken vigorously and left at room temperature
for 10 min. Absorbance of the solution was then
measured spectrophotometrically at 562 nm. The
percentage of inhibition of the ferrozine–Fe2þ
complex formation was calculated by the following
formula:[41]
´
´
´
5. Criado, J. J.; Rodrıguez-Fernandez, E.; Garcıa, E.; Hermosa, M. R.;
Monte, E. Thiourea derivatives of a-aminoacids. Synthesis and
characterization of Ni(II), Cu(II) and Pt(II) complexes with L-valinate
derivatives. Antifungal activity. J. Inorg. Biochem. 1998, 69, 113–119.
6. Huebhr, O. F.; Marsh, J. L.; Mizzoni, R. H.; Mull, R. P.; Schroeder, D. C.;
Troxell, H. A.; Scholz, C. R. A new class of antitubercular compounds. J.
Am. Chem. Soc. 1953, 75, 2274–2275.
Metal chelating ð%Þ ¼ ½ðA0 ꢀ A1Þ=A0ꢆ ꢄ 100
where A0 is the absorbance of control and A1 is the
absorbance in the presence of synthesized
compounds or trolox.
7. Rao, R. P. Thiazolidones and thiazolidiones as fungicidal agents.
Indian J. Appl. Chem. 1960, 23, 110.
8. Madan, V. K.; Taneja, A. D. Synthesis and spectral studies of some
pyrimidyl and thiazolyl substituted thioureas as potential fungicides
and nematicides. J. Indian Chem. Soc. 1991, 68, 471.
9. Schroeder, D. C. Thioureas. Chem. Rev. 1955, 55, 181–228.
10. Rauf, M. K.; Imtiaz-ud-Din; Badshah, A.; Gielen, M.; Ebihara, M.; de
Vos, D.; Ahmed, S. Synthesis, structural characterization and in vitro
cytotoxicity and anti-bacterial activity of some copper(I) complexes
with N,N0-disubstituted thioureas. J. Inorg. Biochem. 2009, 103,
1135–1144.
11. Kostova, I. Gold coordination complexes as anticancer agents. Med.
Chem. 2006, 6, 19–32; a) Ronconi, L.; Giovagnini, L.; Marzano, C.
Gold dithiocarbamate derivatives as potential antineoplastic agents:
design, spectroscopic properties, and in vitro antitumor activity.
Inorg. Chem. 2005, 44, 1867–1881; b) Ronconi, L.; Marzano, C.;
Zanello, P. Gold(iii) dithiocarbamate derivatives for the treatment of
cancer: solution chemistry, dna binding, and hemolytic properties.
J. Med. Chem. 2006, 49, 1648–1657.
Statistical Analysis
Results are expressed as mean ꢃ SD. Statistical
analysis and comparison between mean values for
cytotoxicity were performed by Tukey variance
analysis (SPSS 10.0 for Windows; Chicago, IL, USA).
LSD test was used to analyze the antioxidant
parameters. Level of statistical significance was set
at p < 0.05.
CONCLUSION
12. Milacic, V.; Chen, D.; Ronconi, L.; Kristin, R.; Piwowar, L.; Fregona,
D.; Dou, Q. P. A novel anticancer gold(III) dithiocarbamate compound
inhibits the activity of a purified 20S proteasome and 26S proteasome
in human breast cancer cell cultures and xenografts. Cancer Res.
2006, 66(21), 10478–10486.
13. Daniel, K. G.; Chen, D.; Orlu, S.; Cui, Q. C.; Miller, F. R.; Dou, Q. P.
Clioquinol and pyrrolidine dithiocarbamate complex with copper to
form proteasome inhibitors and apoptosis inducers in human breast
cancer cells. Breast Cancer Res. 2005, 7, R897–R908.
14. Eatock, M. M.; Schatzlein, A.; Kaye, S. B. Tumour vasculature as a
target for anticancer therapy. Cancer Treat Rev. 2000, 26, 191–204.
15. Kuo, H. W.; Chen, S. F.; Wu, C. C.; Chen, D. R.; Lee, J. H. Serum and
tissue trace elements in patients with breast cancer in Taiwan. Biol.
Trace Elem. Res. 2002, 89, 1–11.
16. Margalioth, E. J.; Schenker, J. G.; Chevion, M. Copper and zinc levels
in normal and malignant tissues. Cancer 1983, 52, 868–872.
17. Diez, M.; Arroyo, M.; Cerdan, F. J.; Munoz, M.; Martin, M. A.;
Balibrea, J. L. Serum and tissue trace metal levels in lung cancer.
Oncology 1989, 46, 230–234.
A series of N-ethylpiperazine substitute thiourea
derivatives were prepared by the reaction of 2-ami-
noethyl piperazine with 1-allyl isothiocyanate,
4-methylphenyl isothiocyanate, and 1-naphthyl
isothiocyanate and their Cu(II) complexes were
synthesized. All compounds were tested for their
anticancer activity against MCF-7 and L1210 cell
lines. In addition, synthesized compounds showed
remarkable ferrous ion chelating and radical scav-
enging activities on DPPH and ABTS radicals. These
compounds have shown higher antioxidant activity
than standard antioxidant trolox.
18. Brewer, G. J. Copper control as an antiangiogenic anticancer therapy:
lessons from treating Wilson’s disease. Exp Biol Med (Maywood)
2001, 226, 665–673.
19. Brem, S. Angiogenesis and cancer control: from concept to
therapeutic trial. Cancer Control 1999, 6, 436–458.
20. Daniel, K. G.; Gupta, P.; Harbach, R. H.; Guida, W. C.; Dou, Q. P.
Organic copper complexes as a new class of proteasome inhibitors
and apoptosis inducers in human cancer cells. Biochem. Pharmacol.
2004, 67, 1139–1151.
21. Hochstrasser, M. Ubiquitin, proteasomes, and the regulation of intra-
cellular protein degradation. Curr. Opin. Cell Biol. 1995, 7, 215–223.
22. Wong, K.; Morgan, A. R.; Parachych, W. Controlled cleavage of
phage R17 RNA within the virion by treatment with ascorbate and
copper (II). Can. J. Biochem. 2001, 52, 950–958.
ACKNOWLEDGMENTS
We are indebted to the Adiyaman University
Research Foundation (FEFBAP2010=004) for financial
support of this work.
REFERENCES
´
´
1. Rodrıguez-Fernandez, E.; Manzano, J. L.; Benito, J. J.; Hermosa, R.;
Monte, E.; Criado, J. J. Thiourea, triazole and thiadiazine compounds
and their metal complexes as antifungal agents. J. Inorg. Biochem.
2005, 99, 1558–1572.
189
N-Ethylpiperazine Substitute Thiourea Ligands and Their Cu(II) Complexes